Baird Capital buys Amoena for €102m

Baird Capital Partners Europe has led the buyout of Amoena, a manufacturer of breast prostheses, bras and swimwear for women who have had breast cancer surgery. The private equity firm bought the company for €102.25m ($135m) from Coloplast, a Danish medical company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this